Preview

Problems of Particularly Dangerous Infections

Advanced search

2D-ELECTROPHORESIS IN PROTEIN SPECTRUM CONSTRUCTION FOR EXOPROTEIN FRACTIONS OF PLAGUE AND CHOLERA AGENTS

https://doi.org/10.21055/0370-1069-2017-2-40-44

Abstract

Objective of the study is to apply 2D-electrophoresis for imaging protein spectrum of exoprotein fractions, as well as identification and comparison of biomarker expression of the key pathogenicity factors in plague and cholera agents. Materials and methods. 2D gels of exoprotein fractions were obtained on the model of Vibrio cholerae Inaba 569B, V. cholerae El Tor M888Ctx+ and Ctx– strains, and also Y. pestis EV NIIEG strain. Capsular antigen F1 and cholera toxin were used as biomarkers of major exoproteins of plague and cholera agents. Results and conclusions. While studying cholera toxin through 2D-electrophoresis on IPG strips with pH 3–10 gradient, the antigen fell into a number of protein spots, two of which were close to A1 domain parameters (MW 20.309 kDa and pI 6.51) and B-subunit monomer (MW 11.091 kDa and pI 7.68). Comparative protein spectrum analysis of the exoprotein fractions of V. cholerae Inaba 569B, V. cholerae El Tor M888 Ctx+ and Ctx– has revealed the spots with similar parameters, excluding the strain V. cholerae M888 Ctx– . Investigation of 2D gels of capsular antigen and exoprotein fractions of Y. pestis EV strain has demonstrated that protein spots corresponding to the parameters of the subunit form and diameter of the antigen are present in 37 °C culture patterns. 28 °C culture sample contains F1 subunit in a far lesser concentrations. On the model of toxigenic V. cholerae Inaba 569B strain, isogenic system of V. cholerae El Tor M888 Ctx+ and Ctx– strains, and Y. pestis EV NIIEG strain, high efficiency of 2D-electrophoresis in protein spectrum construction for exoprotein fractions of the cultures, as well as identification and comparison of biomarker expression of major exoproteins of plague and cholera agents is established. 

About the Authors

T. A. Polunina
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005


S. P. Zadnova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005


Ya. M. Krasnov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005


References

1. Kadnikova L.A., Kopylov P.Kh., Dentovskaya S.V., Anisimov A.P. [Capsular antigen of plague microbe]. Infektsiya i Immunitet. 2015; 5(3):201– 18. DOI: http://dx.doi.org/10.15789/2220-7619-2015-3-201-218.

2. Kireev M.N., Taranenko T.M., Khramchenkova T.A., Kravtsov A.L., Guseva N.P., Polunina T.A., Podboronova N.A., Klyueva S.I., Shmel’kova T.P. [Structural-functional properties of capsular antigen F1 preparations during the storage process]. Biotekhnologiya. 2005; 5:41–3.

3. Naumov A.V., Ledvanov M.Yu., Drozdov I.G. [Cholera Immunology]. Saratov; 1995. 69 p.

4. Osterman L.A. [Methods of Investigation of Proteins and Nucleic Acids: Electrophoresis and Ultracentrifugation (Practice Guidelines)]. M.: “Nauka”; 1981. 288 p.

5. Polunina T.A., Varshavskaya Yu.S., Zadnova S.P., Krasnov Ya.M. [Application of 2D-electrophoresis for the construction of “protein profiles” of bacterial cultures lysates of particularly dangerous infections agents]. Probl. Osobo Opasn. Infek. 2016; 1:97–101. DOI: 10.21055/0370-1069- 2016-1-97-101.

6. Serdobintsev L.N., Taranenko, T.M., Verenkov M.S., Naumov A.V. [Production of capsular antigen using single-stage gel filtration]. In: [Problems of Prophylaxis of Natural-Focal Infections]. Saratov; 1983. P. 37–41.

7. Shukolyukov S.A. [Native electrophoresis in cell proteomics: BN- and SN-PAGE]. Tsitologiya. 2011; 53(2):159–65.

8. Andrews G.P., Heath D.G., Anderson G.W., Welkos S.L., Friedlander A.M. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 1996; 64(6):2180–7.

9. Baker E.E., Sommer H., Foster L.E., Meyer E., Meyer K.F. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of the Pasteurella pestis. J. Immunol. 1952; 68(2):131–45.

10. Bharati K., Ganguly N.K. Cholera toxin: a paradigm of a multi-functional protein. Indian J. Med. Res. 2011; 133:179–87.

11. Bradford M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72:248–54.

12. Chromy B.A., Choi M.W., Murphy G.A., Gonzales A.D., Corzett C.H., Chang B.C., Fitch J.P., McCutchen-Maloney S.L. Proteomic characterization of Yersinia pestis virulence. J. Bacteriol. 2005; 187(23):8172–80. DOI: 10.1128/JB.187.23.8172-8180.2005.

13. Iwanaga M., Yamamoto K., Higa N., Ichinose Y., Nakasone N., Tanabe M. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol. Immunol. 1986; 30:1075–83.

14. Gill D.M. The arrangement of subunits in cholera toxin. Biochemistry. 1976; 15:1242–8.

15. Laemmli W.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:80–5.

16. Mekalanos J.J. Production and purification of cholera toxin. Methods Enzymol. 1988; 165:169–75.

17. Runco L.M., Myrczek S., Bliska J.B., Thanassi D.G. Biogenesis of the F1 capsule and analysis of the ultrastructure of Yersinia pestis. J. Bacteriol. 2008; 190(9):3381–5. DOI: 10.1128/JB.01840-07.

18. Spanglert B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992; 56(4):622–47.

19. Vorontsov E.D., Dubichev A.G., Serdobintsev L.N., Naumov A.V. Association-dissociation processes and supermolecular organization of the capsule antigen (protein F1) of Yersinia pestis. Biomed. Sci. 1990; 1(4):391–6.


Review

For citations:


Polunina T.A., Zadnova S.P., Krasnov Ya.M. 2D-ELECTROPHORESIS IN PROTEIN SPECTRUM CONSTRUCTION FOR EXOPROTEIN FRACTIONS OF PLAGUE AND CHOLERA AGENTS. Problems of Particularly Dangerous Infections. 2017;(2):40-44. (In Russ.) https://doi.org/10.21055/0370-1069-2017-2-40-44

Views: 829


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0370-1069 (Print)
ISSN 2658-719X (Online)